Solassol, Isabelle

FDA- and EMA-Approved Tyrosine Kinase Inhibitors in Advanced [electronic resource] - Biomolecules 10 2019

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

2218-273X

10.3390/biom9110668 doi


Carcinoma, Non-Small-Cell Lung--blood
Drug Approval
ErbB Receptors--antagonists & inhibitors
Europe
Humans
Lung Neoplasms--blood
Mutation
Protein Kinase Inhibitors--adverse effects
Safety
United States
United States Food and Drug Administration--legislation & jurisprudence